Evidence map›Paper›PMID 42439308›Full record

SynthesisHealth technology assessment (Winchester, England)2026

Surgery for early structural osteoarthritis of the hip and knee: the SCORE evidence synthesis and economic evaluation.

Andrew Price, Emma Searle, Maggie Westby, Gianluca Fabiano, Pamela Royle, Jill Colquitt, Emma Loveman, Karen Barker, Sion Glyn-Jones, Antony Palmer and 5 more

Abstract readSystematic Review
In one paragraph

Synthesis in Health technology assessment (Winchester, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andrew PriceNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.ORCID 0000-0002-4258-5866
Emma SearleNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.
Maggie WestbyNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.ORCID 0000-0003-4273-3942
Gianluca FabianoNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.ORCID 0000-0001-9922-4810
Pamela RoyleWarwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0001-5175-1005
Jill ColquittSouthampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK.ORCID 0000-0001-5962-2689
Emma LovemanSouthampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK.ORCID 0000-0001-8226-2634
Karen BarkerNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.ORCID 0000-0001-9363-0383
Sion Glyn-JonesNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.ORCID 0000-0002-8521-7342
Antony PalmerNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.ORCID 0000-0003-4616-7482
Hema MistryWarwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0002-5023-1160
Toby SmithWarwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0003-1673-2954
Andy MetcalfeWarwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0002-4515-8202
Rafael Pinedo- VillanuevaNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.ORCID 0000-0002-4723-5128
Sally HopewellNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Botnar Institute, Nuffield Orthopaedic Centre, Oxford, UK.ORCID 0000-0002-6881-6984

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research question: Is surgery for early hip or knee osteoarthritis clinically effective and cost-effective? Background: Osteoarthritis is the most common joint disease worldwide costing between 1% and 2.5% of gross domestic product in developed countries. Once a hip or knee develops end-stage disease, arthroplasty surgery is highly successful in most patients. Treatment options are limited for early disease, and patients may fall into a 'treatment gap', despite having severe symptoms. Many surgical procedures are used to treat early osteoarthritis of the hip and knee, but the clinical and cost-effectiveness of these techniques remains unclear. Overall aim: To investigate the role of surgery in the management of early hip or knee osteoarthritis? Objectives: Use systematic review and evidence synthesis to determine the clinical effectiveness of current surgical interventions for early hip and knee osteoarthritis. Estimate the cost-effectiveness of these procedures using decision model analytic modelling. Create clinical treatment guidance and identify areas where new clinical research is required. Methods: The programme of work consisted of systematic review, evidence synthesis and health economic modelling for surgical treatments used for early hip and knee osteoarthritis. We divided treatments into four groups: (1) non-regenerative procedures, (2) regenerative procedures, (3) load-modifying procedures and (4) arthroplasty procedures. They were compared with non-surgical treatment following National Institute for Health and Care Excellence guidance. We used outcome measures that satisfied the Outcome Measures in Rheumatoid Arthritis Clinical Trials and Osteoarthritis Research Society International core outcome set for hip and knee osteoarthritis. Decision-analytic models were developed to assess the cost-effectiveness of treatment alternatives expressed as cost per quality-adjusted life-year gained. Results: The systematic review identified 61,098 studies, and our evidence synthesis identified a number of surgical techniques that have been used to treat early hip and knee osteoarthritis. However, we found very little meaningful evidence of the clinical efficacy for the majority of the surgical procedures. We only found seven randomised controlled trials and three non-randomised studies that compared a surgical technique to non-operative treatment. There were two surgical treatments that had limited but supportive evidence. Femoro-acetabular impingement is an early stage of hip osteoarthritis, and there is some evidence that arthroscopic chondroplasty provides patients with clinical relief of symptoms, above that seen with non-operative measures. In the knee, weaker evidence suggests arthroscopic debridement of osteoarthritic articular cartilage fragments may be of benefit, above non-operative measures. Health economic analysis suggests that both procedures may be cost-effective, but the evidence is again of low quality. Limitations: The original updated searches completed in January 2021, with a further search for randomised controlled studies completed in January 2025. Conclusions: There is a significant gap in the evidence base supporting surgical interventions in early hip and knee osteoarthritis. Limited evidence suggests that arthroscopic chondroplasty procedures may be effective in treating hip femoro-acetabular impingement and early knee osteoarthritis. A small number of randomised studies are in progress, but these studies do not encompass all procedures that are in use. Future work: The key recommendation for future work is that more high-quality comparative studies are required to establish if the surgical interventions that are currently used are effective. Study registration: This study is registered as PROSPERO CRD42019156444. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR127398) and is published in full in

Indexed as

Osteoarthritis, HipOsteoarthritis, KneeArthroplasty, Replacement, KneeCost-Benefit AnalysisCost-Effectiveness AnalysisHumansQuality-Adjusted Life YearsEARLY OSTEOARTHRITISEVIDENCE SYNTHESISHEALTH ECONOMICSOUTCOMESURGERY

Identifiers

PMID42439308
PMCPMC13403056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.